Movement Disorders Journal Podcasts 2012-2015
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
- Autor: Podcast
- Narrador: Podcast
- Editor: Podcast
- Duración: 0:02:32
- Mas informaciones
Informações:
Sinopsis
Movement Disorders Journal Podcasts 2012-2015